Skip to content Skip to site navigation Skip to local navigation
Department of Health and Aged Care Department of Health and Aged Care

Medical Services Advisory Committee

  • MSAC
  • About MSAC
    • About MSAC
    • MSAC Terms of Reference
    • MSAC Membership
    • MSAC Executive Terms of Reference
    • ESC Terms of Reference
    • ESC Membership
    • PASC Terms of Reference
    • PASC Membership
  • MSAC Meetings
    • PASC, ESC, MSAC Key Dates
    • Codependent Technologies
    • Meeting Agendas
  • MSAC Processes
    • How to Apply for Public Funding
    • MSAC Process Framework
    • Frequently Asked Questions
    • Fact Sheets
  • Forms Templates & Guidelines
    • MSAC Guidelines
    • Documents for Applicants and Assessment Groups
    • Additional Resources
  • Engaging with MSAC
    • Information for Applicants
    • MSAC Consultation Process
  • MSAC Applications
    • Application Page
  • Utilisation Monitoring Process
  • You are here:
  • Medical Services Advisory Committee /
  • MSAC Meetings /

PASC Meeting – 9–10 December 2021

Page last updated: 25 September 2023 (this page is generated automatically and reflects updates to other content within the website)

PICO Advisory Sub-Committee – Applications considered


  • 1555.1 – Endoscopic sleeve gastroplasty for the treatment of patients with Class I and II obesity who have failed first line (lifestyle modification) and second line (pharmacotherapy) treatments
  • 1657 – Rhenium-188 brachytherapy for non-melanoma skin cancer
  • 1665 – Radiofrequency echographic multi spectrometry for bone density measurement and determination of osteopenia/osteoporosis
  • 1675 – Whole Genome Sequencing for the diagnosis of mitochondrial disease
  • 1680 – Genetic testing for childhood hearing impairment
  • 1684 – Genetic testing for variants associated with haematological malignancies
  • 1685 – Ventral rectopexy for the treatment of rectal prolapse and intussusception
  • 1686 – 177Lutetium PSMA i&t for metastatic castrate resistant prostate cancer
  • 1689 – Quantification of NT-proBNP in patients with systemic sclerosis, and in patients with diagnosed pulmonary arterial hypertension
  • 1690 – Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell to treat refractory or relapsed multiple myeloma
  • 1691 – PromarkerD testing in patients with type 2 diabetes to determine the risk of developing diabetic kidney disease
Listen
  • MSAC Meetings
  • PASC, ESC, MSAC Key Dates
  • Codependent Technologies
  • Meeting Agendas
  • MSAC Email Bulletin


  • Feedback
Provide feedback

Comments will be used to improve web content and will not be responded to.

Real person check

This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software.


Privacy statement

Your feedback has been submitted

Thank you for taking the time to provide feedback. It will be used to make improvements to this website.

Medical Services Advisory Committee

Medical Services Advisory Committee

© Commonwealth of Australia
ABN: 83 605 426 759

MBS Information

  • MBS Online
  • Legislation that covers the MBS
  • About MBS Factsheets
  • MBS Review

HTA Information

  • What is HTA
  • Australian Government HTA processes

Useful Links

  • MBS Online
  • PBS
  • PBAC
  • PLAC
  • Health Technology Reference Group
  • Healthier Medicare
  • MBS Review
  • TGA
  • HTA Conflict of Interest Guide

About

  • Copyright
  • Linking to this site
  • Accessibility
  • Disclaimer
  • Privacy
  • What is RSS?
  • Contact Us